C12Y402/01001

Carbon dioxide conversion reactor, series reactor for converting and capturing carbon dioxide including the same, and process of converting and capturing carbon dioxide using the same

The present invention relates to a carbon dioxide conversion reactor and more particularly, to a carbon dioxide conversion reactor capable of converting carbon dioxide contained in flue gas into an aqueous bicarbonate solution that may be used in many applications; and at the same time, preventing back pressure from increasing due to supplied flue gas by allowing a conversion process to rapidly proceed, thereby significantly reducing the level of carbon dioxide contained in flue gas with high efficiency and high conversion speed, a series reactor for converting and capturing carbon dioxide including the carbon dioxide conversion reactor, and a process of converting and capturing carbon dioxide using the carbon dioxide conversion reactor.

METHOD FOR MANAGING PAIN
20210128704 · 2021-05-06 ·

The invention provides a method of treating or preventing pain in a subject in need thereof. The method comprising administering to the subject an expression vector comprising a nucleic acid sequence encoding carbonic anhydrase (10) or carbonic anhydrase (11) such that the nucleic acid is expressed to produce carbonic anhydrase (10) or carbonic anhydrase (11). Alternatively, the method comprising administering to the subject an expression vector comprising a nucleic acid sequence encoding a carbonic anhydrase (8) fragment such that the nucleic acid is expressed to produce the carbonic anhydrase (8) fragment.

ORGANIC LIGHT EMITTING DIODE DISPLAY WITH COLOR-CORRECTION COMPONENT AND METHOD OF MAKING SAME

An OLED display including a display panel and a color-correction component is described. A plurality of comparative display panels otherwise equivalent to the display panel but having one or more different optical thicknesses of OLED layers have a maximum white-point color shift from 0 to 45 degrees of WPCS.sup.C.sub.45 and a white-point axial efficiency of WPAE.sup.C. The plurality of comparative display panels defines a performance curve along a boundary of performance points. The OLED display and the display panel have respective maximum white-point color shifts from 0 to 45 degrees of WPCS.sub.45 and WPCS.sup.0.sub.45 and respective white-point axial efficiencies of WPAE and WPAE.sup.0. WPCS.sup.0.sub.45 and WPAE.sup.0 defines a performance point of the display panel to the right of the performance curve and WPCS.sub.45 and WPAE defines a performance point of the OLED display above or to the left of the performance curve. Methods of making the OLED display are described.

CO.SUB.2 .capture methods using <i>Thermovibrio ammonificans </i>carbonic anhydrase

Methods for enzyme-enhanced CO.sub.2 capture include contacting a CO.sub.2-containing gas with an aqueous absorption solution at process conditionssuch as high temperature, high pH, and/or using carbonate-based solutionsin the presence of Thermovibrio ammonificans carbonic anhydrase (TACA) or functional derivative thereof for catalyzing the hydration reaction of CO.sub.2 into bicarbonate and hydrogen ions and/or catalyzing the desorption reaction to produce a CO.sub.2 gas. The TACA may be provided to flow with the solution to cycle through a CO.sub.2 capture system that includes an absorber and a stripper.

Heat-stable metagenomic carbonic anhydrases and their use

The present invention relates to polypeptides having carbonic anhydrase activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.

BICYCLIC PEPTIDE LIGANDS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

METHOD FOR TREATING GLIOBLASTOMA
20210052644 · 2021-02-25 ·

Disclosed is a method for treating glioblastoma or other brain tumors. The method includes steps of preparing cells comprising a chimeric antigen receptor (CAR) molecule and administering to a mammal in need thereof an effective amount of the prepared cells. Also disclosed is that the CAR molecule contains an antigen binding domain that binds to the tumor antigen associated with the glioblastoma or other brain tumors, and the tumor antigen is carbonic anhydrase IX.

CA2 COMPOSITIONS AND METHODS FOR TUNABLE REGULATION

The present disclosure provides drug responsive domains derived from human carbonic anhydrase 2 that can modulate protein stability for human interleukin 15 (IL15) payloads, as well as compositions and methods of use thereof.

Heat-resistant carbonic anhydrase mutants and composition for capturing carbon dioxide containing the same

Disclosed are a carbonic anhydrase mutant having heat resistance at a high temperature of 80 C. as well as excellent activity to capture carbon dioxide and a composition for capturing carbon dioxide containing the same. The heat-resistant carbonic anhydrase mutant can be applied to a high-temperature carbon dioxide capture process due to high stability at high temperatures and a high carbon dioxide hydration rate.

IMMOBILIZATION OF PROTEINS WITH CONTROLLED ORIENTATION AND LOAD
20210072238 · 2021-03-11 · ·

Methods for immobilizing a protein or functional protein fragment on a surface in a controlled orientation, for immobilizing a protein or functional protein fragment on a surface with efficient immobilization loading of the protein or protein fragment, and for immobilizing a protein or functional protein fragment on a surface with retention of the activity of the protein or protein fragment. In the methods, a tetrazine-modified protein or a tetrazine-modified functional protein fragment is contacted with a trans-cyclooctene-modified surface to provide a surface having the protein or functional protein fragment immobilized thereon. Surfaces having a protein or functional protein fragment immobilized thereon obtainable by the method and methods for using the surfaces for measuring the binding of a ligand to a protein or functional protein fragment.